BioCentury
ARTICLE | Company News

Intellect Neurosciences, Northwestern University deal

May 14, 2012 7:00 AM UTC

The university granted Intellect an exclusive license to antibodies tauC3 and TOC-1, which target early neurotoxic forms of tau protein that are associated with cell death characteristic of Alzheimer'...